Group 1 - Company Jiukang Bio (SZ 300406) announced on October 31 that it has received three patent certificates from the National Intellectual Property Administration of the People's Republic of China, including "A Digoxin Detection Kit" and "Fully Automatic Coagulation Analyzer" [1] - For the year 2024, Jiukang Bio's revenue composition is 100% from the healthcare sector [1] - As of the report date, Jiukang Bio has a market capitalization of 8 billion yuan [1]